BSU bulletin. Economy and Management
Bibliographic description:
, , PHARMACEUTICAL INDUSTRY IN RUSSIA: ANALYSIS AND ECONOMIC ASPECTS OF DEVELOPMENT // BSU bulletin. Economy and Management. - 2020. №3. . - С. 31-40.
Title:
PHARMACEUTICAL INDUSTRY IN RUSSIA: ANALYSIS AND ECONOMIC ASPECTS OF DEVELOPMENT
Financing:
Codes:
Annotation:
Over the past 10 years the pharmaceutical industry in Russia has been a dynamically
growing non-resource sector of the economy and demonstrated active sustainable growth every year, surpassing the growth of the rest of the economy as a whole. The article analyzes the development of the industry in terms of the main economic indicators over the past 7–10 years in comparison with the most important indicators of the national economy; the main gross indicators and indices of organizations by type of economic activity: production of pharmaceutical products, pharmaceutical substances, medicinal drugs and materials used for medical purposes. We have revealed the main trends of fixed investments in the pharmaceutical industry, determined the structure of the volume of shipped own-produced goods, executed services by forms of ownership, and shown business confidence indexes of manufacturing and pharmaceutical organizations. The article presents the results of state policy set in Federal Target Program "PHARMA–2020", which is aimed at the development of pharmaceutical industry, as well as new priorities of the draft strategy "PHARMA–2030".
growing non-resource sector of the economy and demonstrated active sustainable growth every year, surpassing the growth of the rest of the economy as a whole. The article analyzes the development of the industry in terms of the main economic indicators over the past 7–10 years in comparison with the most important indicators of the national economy; the main gross indicators and indices of organizations by type of economic activity: production of pharmaceutical products, pharmaceutical substances, medicinal drugs and materials used for medical purposes. We have revealed the main trends of fixed investments in the pharmaceutical industry, determined the structure of the volume of shipped own-produced goods, executed services by forms of ownership, and shown business confidence indexes of manufacturing and pharmaceutical organizations. The article presents the results of state policy set in Federal Target Program "PHARMA–2020", which is aimed at the development of pharmaceutical industry, as well as new priorities of the draft strategy "PHARMA–2030".
Keywords:
pharmaceutical sector; pharmaceutical industry; "PHARMA–2020" strategy; "PHARMA–2030" strategy.
List of references:
Article.pdf